Work

National trends in neoadjuvant chemotherapy utilization for cT1-2 N0 triple negative breast cancer: Did the CREATE-X trial impact treatment patterns?

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.e12599

Authors: Christine Rogers, Jan Irene Lloren, Morgan K. Johnson, Adrienne Cobb, Lubna Naaz Chaudhary, Chiang-Ching Huang, Mediget Teshome, Puneet Singh, Amanda L. Kong, Chandler Scott Cortina

Institutions: Medical College of Wisconsin, University of Wisconsin–Milwaukee, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Medical College of Wisconsin

OpenAlex ID: W4379284131

Cites:

Cited by:

Related to: 10